Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -16.292\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1
b) COc1ccc(CCN2CC(C(=O)NCC3(O)CCCCC3)CCC2=O)cc1
c) O=C(COc1ccc(Nc2ccccc2)cc1)OCC(=O)N1CCCCC1
d) COc1ccc(S(=O)(=O)Cc2ccc(C(=O)NC3CCC(C)CC3)o2)cc1
e) CCOC(=O)C1(CC2CC2)CCN(C(=O)c2cc(C3CC3)nc3ccccc23)CC1
Answer: a. CCOc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1
CCOc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1
N-(4-ethoxyphenyl)-2-morpholin-4-yl-5-nitrobenzamide